Stockscreener 앱 받기
15.71
0.57%
-0.010
Rallybio Corp 주식(RLYB)의 최신 뉴스
RLYB Stock Hits 2-Year Highs After Unveiling Merger With Avenzo – How Much Of The New Company Will Rallybio Shareholders Own? - Stocktwits
Rallybio Corporation(NasdaqCM: RLYB) added to Russell Microcap Value Benchmark Index - marketscreener.com
Rallybio Corporation(NasdaqCM: RLYB) added to Russell Microcap Index - marketscreener.com
RLYB stock hits 2-year highs after unveiling merger with Avenzo – how much of the new company will Rallybio shareholders own? - MSN
What's Driving Rallybio's Recent Surge and Investor Interest - Kavout | AI
Rallybio Corporation Actuals & Estimates (NASDAQ:RLYB) - TradingView
Rallybio Corp (RLYB) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Rallybio Corp (RLYB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Rallybio Corp (RLYB) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Rallybio Corp (RLYB) Valuation: PE, PB & Fair Value Analysis - TradingKey
Rallybio Corp (RLYB) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Rallybio Corp (RLYB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Rallybio Corp (RLYB) Institutional Confidence - TradingKey
Rallybio Corp (RLYB) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Rallybio Corp (RLYB) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Rallybio Company Profile & Introduction - Moomoo
Are SUNE, RLYB, ASRT, TMHC Obtaining Fair Deals for their Shareholders? - The Malaysian Reserve
JOHNSON & JOHNSON's Rallybio Corp(RLYB) Holding History - GuruFocus
San Diego Biotech Upstart Avenzo Plots Nasdaq Splash In Rallybio Reverse Merger - Hoodline
United StatesMintz Advising On $215 Million Private Placement Concurrent With Avenzo Therapeutics’ And Rallybio’s Merger Transaction - Mondaq
Avenzo Picks Up Reverse Merger Ditched by Candid - San Diego Business Journal
ADAR1, Daniel Schneeberger disclose 17.5% stake in Rallybio (RLYB) - Stock Titan
Adar1 Capital, Daniel Schneeberger buy $2.18m Rallybio stock - Investing.com
Mintz Advising on $215 Million Private Placement Concurrent with Avenzo Therapeutics’ and Rallybio’s Merger Transaction - Mintz
Rallybio Investor Alert: Kahn Swick & Foti, LLC Investigates Merger of Rallybio CorporationRLYB - Business Wire
Shareholder Alert: Ademi LLP investigates whether Rallybio Corpo - GuruFocus
Halper Sadeh LLC is Investigating Whether RLYB, KALV, INM, TMHC are Obtaining Fair Deals for their Shareholders - GlobeNewswire
Shareholder Alert: Ademi LLP investigates whether Rallybio Corporation is obtaining a Fair Price for Public Shareholders - PR Newswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
Rallybio, Avenzo agree oncology reverse merger backed by $215 million financing - The Pharma Letter
Rallybio to Raise $215M Via Pvt Placement >RLYB - Moomoo
Rallybio: Placement Expected to Fund Ops Into Late 2028 >RLYB - Moomoo
Rallybio: Combined Co Expected to Operate As Avenzo Therapeutics >RLYB - Moomoo
RLYB: Merger leverages oncology expertise and $215M funding to advance clinical programs and milestones - TradingView
RLYB: Merger accelerates oncology pipeline with $215M funding and late 2028 cash runway - TradingView
Rallybio finds a new reverse-merger dance partner in Avenzo - FirstWord Pharma
RallyBio tries again for reverse merger, this time with Avenzo - BioPharma Dive
1.16%
0.48%
자본화:
|
볼륨(24시간):